<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02488577</url>
  </required_header>
  <id_info>
    <org_study_id>MISS-TRICKR2</org_study_id>
    <nct_id>NCT02488577</nct_id>
  </id_info>
  <brief_title>Outcomes of TAMIS-Total Mesorectal Excision Versus Transanal Loco-regional Excision for T2 Low Rectal Cancer</brief_title>
  <acronym>TAMIS</acronym>
  <official_title>Outcomes Comparison of TAMIS-TME Versus Transanal Minimally Invasive Locoregional Resection for T2 Low Rectal Cancer: an Open Label Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Osama Mohammad Ali ElDamshety</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cases with stage T2 N0 low rectal cancer will undergo either Transanal minimally invasive
      total mesorectal excision or transanal minimally invasive locoregional resection.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>June 2015</start_date>
  <completion_date type="Anticipated">October 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Overall percent of postoperative complications.</measure>
    <time_frame>30 days</time_frame>
    <description>the over all percentage of Postoperative complications concerning Pelvis abscess, anastomosis disruption, bleeding, Fistula and continence function.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hospital stay</measure>
    <time_frame>30 days</time_frame>
    <description>Number of Days starting from the admission till discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recurrence.</measure>
    <time_frame>2 years</time_frame>
    <description>number of local and distant recurrence</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Low Rectal Cancer</condition>
  <arm_group>
    <arm_group_label>TAMIS TME</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>T2 N0 Cases which undergo transanal minimally invasive total mesorectal excision.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TAMIS-Local</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>T2 N0 Cases which will undergo transanal minimally invasive locoregional resection.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Transanal minimally invasive total mesorectal excision</intervention_name>
    <arm_group_label>TAMIS TME</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>transanal minimally invasive locoregional resection</intervention_name>
    <arm_group_label>TAMIS-Local</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  T2 N0 low rectal cancer

        Exclusion Criteria:

          -  patients unfit for laparoscopic resection

          -  Unwilling to share in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sherif Kotb, M.D., PhD.</last_name>
    <role>Study Director</role>
    <affiliation>Professor of surgical oncology Mansoura university</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Osama Eldamshety, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>surgical oncology Mansoura university</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Adel Fathi, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>surgical oncology Mansoura university</affiliation>
  </overall_official>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 30, 2015</study_first_submitted>
  <study_first_submitted_qc>July 1, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 2, 2015</study_first_posted>
  <last_update_submitted>July 1, 2015</last_update_submitted>
  <last_update_submitted_qc>July 1, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 2, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Mansoura University</investigator_affiliation>
    <investigator_full_name>Osama Mohammad Ali ElDamshety</investigator_full_name>
    <investigator_title>Assistant lecturer of surgical oncology.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rectal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

